Teddi Mellencamp opens up about Stage 4 melanoma diagnosis, how her kids are coping
Teddi Mellencamp is sharing new details about her Stage 4 melanoma diagnosis and how she is coping with an uncertain future ...
Teddi Mellencamp says her melanoma is now stage 4
Teddi Mellencamp has shared a health update. The "Real Housewives of Beverly Hills" alum disclosed in a post on social media ...
Teddi Mellencamp Confirms She Has Stage 4 Melanoma In Emotional Interview After Cancer Spread To Her Lungs And Brain
Real Housewives of Beverly Hills star Teddi Mellencamp confirmed her cancer has advanced into Stage 4 melanoma that has ...
CURE4d
First Patient Dosed in Trial of [212Pb]VMT01 for Metastatic Melanoma
The first patient has been dosed with [212Pb]VMT01 in a phase 1/2a trial evaluating the safety of the agent in patients with ...
Us Weekly on MSN1d
Teddi Mellencamp Has 4 More Brain Tumors: Inside Her Cancer Battle as She Fights for Her Life (Exclusive)
RHOBH’ alum Teddi Mellencamp exclusively told Us Weekly about her heart wrenching cancer battle and where she still finds ...
Healio3d
Ipilimumab plus nivolumab ‘considered a cure’ long term for melanoma brain metastasis
Seven-year follow-up data of a multicenter, randomized phase 2 study evaluating the treatment of melanoma brain metastases shows ipilimumab plus nivolumab is an effective long-term care option. First ...
Morningstar4d
Innovent Receives NMPA Breakthrough Therapy Designation for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma
a first-in-class PD-1/IL-2α-bias bispecific antibody fusion protein, as monotherapy for the treatment of unresectable locally advanced or metastatic mucosal or acral melanoma who have not ...
Us Weekly’s 5 Hot Stories: Inside Teddi Mellencamp’s cancer battle, Cher honors late ex Val Kilmer
In a new cover story, Real Housewives of Beverly Hills alum Teddi Mellencamp exclusively opened up to Us Weekly about her ...
Melanoma nightmare: Former CEO tells of wife’s devastating diagnosis after mole removed
The former CEO of global restaurant giant Collins Foods has opened up for the first time since losing his wife to melanoma, ...
Immatics N.V.: Trading Below Cash, But Not Without Reason
Immatics' lead asset, IMA203, shows promising early data with a 57% ORR in heavily pretreated patients, but toxicity concerns ...
manilatimes4d
Innovent Receives NMPA Breakthrough Therapy Designation for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma
a first-in-class PD-1/IL-2 α-bias bispecific antibody fusion protein, as monotherapy for the treatment of unresectable locally advanced or metastatic mucosal or acral melanoma who have not received ...